When we first featured a guest discussing GLP-1 therapies, the public’s understanding of these drugs to treat obesity was still developing. In 2023, our expert was Dr. Jamy Ard, the then-incoming president of The Obesity Society. Even then, Dr. Ard was stressing that more choices would lower prices for consumers. We look back on that […]

The post GLP-1 Therapies: Where We’ve Been & Where We’re Going appeared first on Healthy Communities Online.